NCT02685956View on ClinicalTrials.gov

Clinical Evaluation of the Sentosa SA HSV1/2 Qualitative PCR Test

CompletedOBSERVATIONAL
Enrollment

2,295

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

April 7, 2017

Study Completion Date

April 7, 2017

Conditions
Herpes Simplex
Interventions
DEVICE

Vela Sentosa SA HSV1/2 Qualitative PCR Test

medical device test using Vela Sentosa SA HSV1/2 Qualitative PCR Test

Trial Locations (9)

15261

University of Pittsburgh, Pittsburgh

17822

Geisinger Health, Danville

19044

Quest Diagnostics, Horsham

33606

Tampa General Hospital, Tampa

44195

Cleveland Clinic, Cleveland

48073

Beaumont Health, Royal Oak

75067

MedFusion, Lewisville

01199

Baystate Health, Springfield

07407

BioReference Labs, Elmwood Park

Sponsors

Lead Sponsor

Vela Diagnostics
All Listed Sponsors
lead

Vela Diagnostics

INDUSTRY

NCT02685956 - Clinical Evaluation of the Sentosa SA HSV1/2 Qualitative PCR Test | Biotech Hunter | Biotech Hunter